85 completed, 25 recruiting, 21 unknown, 10 not yet recruiting. 167 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 167 | Completed 85, Recruiting 25, Unknown 21, Not yet recruiting 10, Terminated 9, Active not recruiting 7, Withdrawn 5, Suspended 3, Enrolling by invitation 2 |
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The MInimizing RIsk of CLotting Events Trial VTE Risk Assessment CDS Tool - Venous Thromboembolism (VTE) | Not applicable | Not yet recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 65000 | 2026-11-01 | 2026-11-12 |
| Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty Apixaban, Rivaroxaban, Enoxaparin (LMWH) - Total Knee Arthroplasty, Venous Thromboembolism | Not applicable | Recruiting | Military Hospital of Tunis | 138 | 2026-09-15 | 2026-10-16 |
| Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism DECIDE-VTE Patient Decision Aid - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT) | Not applicable | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 850 | 2026-09-01 | 2026-06-24 |
| Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism mobile venous thromboembolism application (mVTEA) - Venous Thromboembolism, Pulmonary Thromboembolisms | Not applicable | Recruiting | Navy General Hospital, Beijing | 2972 | 2026-08-20 | 2026-09-09 |
| The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial. Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity | Not applicable | Not yet recruiting | University College Dublin | 180 | 2026-08-01 | 2026-05-18 |
| Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study) Systematic screening for pulmonary embolism in all patients using a guideline-recommended diagnostic algorithm - Acute Heart Failure (AHF), Pulmonary Embolism (Diagnosis) | Not applicable | Recruiting | University Hospital, Angers | 740 | 2026-07-15 | 2026-07-17 |
| Delivery and Implementation of a Randomised Crossover Trial on Thrombosis Patients in hospitals allocated to this arm will receive aspirin as their routine thromboprophylaxis after surgery., Low molecular weight heparin (LMWH) - Hip Fractures, Venous Thromboembolism (VTE) | Not applicable | Recruiting | Queen Mary University of London | 21194 | 2026-07-01 | 2026-09-23 |
| Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF) Stepwise Anticoagulation Regimen, Standard Anticoagulation Regimen - Non-valvular Atrial Fibrillation (NVAF), Thromboembolism | Not applicable | Not yet recruiting | Fu Wai Hospital, Beijing, China | 424 | 2026-05-26 | 2026-06-01 |
| Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial Enoxaparin standard dose, Enoxaparin intermediate dose - Severe Trauma Patient, Venous Thromboembolism | Not applicable | Not yet recruiting | University Hospital, Grenoble | 540 | 2026-04-01 | 2026-04-29 |
| Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism MSK-ACCESS, ctDNA/VTE Risk Score: - Venous Thromboembolism, Deep Venous Thrombosis | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 259 | 2026-01-30 | 2026-11-09 |
| Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism Exercise-based rehabilitation program - Venous Thromboembolism (VTE), Exercise Therapy | Not applicable | Recruiting | Insel Gruppe AG, University Hospital Bern | 160 | 2025-12-17 | 2026-06-12 |
| Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes Rivaroxaban, Enoxaparin 40 mg - Postpartum Period, Cesarean Section Surgery | Not applicable | Recruiting | Wolfson Medical Center | 62 | 2025-12-01 | 2026-09-15 |
| Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER ) Usual Care Group, shared decision-making process - Venous Thromboembolism | Not applicable | Recruiting | University Hospital, Brest | 2400 | 2025-10-30 | 2025-11-28 |
| Informative Video Before LMWH Postpartum - Randomized Controlled Trial Informative Video on LMWH, Standard Verbal Explanation - Venous Thromboembolism (VTE), Postpartum Care | Not applicable | Not yet recruiting | Wolfson Medical Center | 160 | 2025-10-15 | 2025-09-11 |
| Implementing VTE Prevention in Ambulatory Cancer Care Clinical program - Venous Thromboembolism, Neoplasms | Not applicable | Enrolling by invitation | University of Vermont | 25 | 2025-10-01 | 2025-12-18 |
| Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk 4G tablet - Thromboembolic Disease | Not applicable | Recruiting | Centre Hospitalier Eure-Seine | 50 | 2025-09-01 | 2025-09-15 |
| Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation NOAC discontinuation, NOAC continuation, Smartwatch single-lead ECG monitoring - Atrial Fibrillation (AF) | Not applicable | Recruiting | Beijing Anzhen Hospital | 4100 | 2025-08-05 | 2026-03-04 |
| CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism The multifaceted interventions, Routine VTE prophylaxis - Venous Thromboembolic Disease, Pulmonary Embolism | Not applicable | Recruiting | China-Japan Friendship Hospital | 5800 | 2025-08-01 | 2025-09-17 |
| The Effect of a VTE Prevention Care Bundle in Total Hip Arthroplasty Patients VTE Prevention Care Bundle, Standard Routine Care - Venous Thromboembolism, Total Hip Arthroplasty (THA) | Not applicable | Active not recruiting | Murat Erten | 110 | 2025-06-17 | 2026-07-14 |
| The Protrieve PROTECTOR Study Percutaneous mechanical thrombectomy (PMT) - Venous Thromboembolism, Deep Venous Thrombosis | Not applicable | Completed | Inari Medical | 66 | 2025-03-05 | 2026-10-05 |
Showing 20 of 167. Sign in to see all of them.
Venous Thromboembolism (110) · Pulmonary Embolism (35) · Venous Thrombosis (33) · Thrombosis (15) · Atrial Fibrillation (14) · Stroke (13) · Intracranial Embolism (7) · Intracranial Thrombosis (7) · Hemorrhage (6) · Neoplasms (6) · Cardiovascular Diseases (5) · Wounds and Injuries (5) · COVID-19 (4) · Embolism (4)
Embolism and Thrombosis (165) · Vascular Diseases (163) · Cardiovascular Diseases (162) · Pathological Conditions, Signs and Symptoms (47) · Respiratory Tract Diseases (42) · Lung Diseases (40) · Pathologic Processes (40) · Nervous System Diseases (36) · Embolism (33) · Central Nervous System Diseases (31) · Brain Diseases (29) · Thrombosis (29) · Cerebrovascular Disorders (27) · Heart Diseases (20)
Enoxaparin (13) · Rivaroxaban (12) · Warfarin (8) · apixaban (7) · Heparin, Low-Molecular-Weight (6) · Aspirin (4) · Dalteparin (4) · Heparin (4) · Blood Specimen Collection (3) · Dabigatran (3) · Fondaparinux (3) · edoxaban (3) · Educational Status (2) · Endarterectomy, Carotid (2) · Standard of Care (2)
Brigham and Women's Hospital (4) · Hospices Civils de Lyon (4) · Insel Gruppe AG, University Hospital Bern (4) · University Hospital, Brest (4) · Inari Medical (3) · Johns Hopkins University (3) · Karolinska University Hospital (3) · Navy General Hospital, Beijing (3) · Vanderbilt University Medical Center (3) · Assistance Publique Hopitaux De Marseille (2) · BiO2 Medical (2) · Imperial College London (2) · M.D. Anderson Cancer Center (2) · Memorial Sloan Kettering Cancer Center (2) · National Heart, Lung, and Blood Institute (NHLBI) (2)
United States (57) · France (23) · China (14) · Canada (10) · United Kingdom (10) · Switzerland (8) · Australia (6) · Israel (5) · Italy (4) · Russia (4) · Turkey (Türkiye) (4) · Germany (3) · Netherlands (3) · Sweden (3) · Belgium (2)
Alok Kapoor, MD (2) · Amihai Rottenstreich, MD (2) · Elliott R Haut, MD PhD (2) · Paul W Ackermann, MD, PhD (2) · Victor Tapson, MD (2) · Abdulhameed Gasim, MD (1) · Adam Cuker, MD (1) · Alex Spyropoulos, MD (1) · Allison P Wheeler, MD (1) · Alun Davies (1) · Alun H Davies (1) · Alvar Agusti, MD, PhD (1)
PMID 34597414, PMID 33779986, PMID 11867132, PMID 11982463, PMID 12131409, PMID 14987333, PMID 15132746, PMID 15234649, PMID 15319720, PMID 15811953, PMID 15842354, PMID 16009794, PMID 16307934, PMID 16456434, PMID 17215729, PMID 18086925, PMID 19036065, PMID 19458109, PMID 19875061, PMID 19878532, PMID 20332509, PMID 20386359, PMID 20622663, PMID 20626619, PMID 21900088, PMID 22315257, PMID 22315263, PMID 22315264, PMID 23013426, PMID 23303884, PMID 2352304, PMID 23780517, PMID 24141714, PMID 24195920, PMID 25922463, PMID 25940537, PMID 26095467, PMID 26201391, PMID 26672686, PMID 26699594, PMID 26817957, PMID 26868660, PMID 27126650, PMID 27349472, PMID 27440463, PMID 27605222, PMID 27764880, PMID 27900179, PMID 28367699, PMID 28668970
2025 (2), 2017 (1), 2019 (1), K23HL112908 (1), K23HL132054 (1), P30CA016672 (1), P30CA138313 (1), R01HL164482 (1), U01HL063942 (1)